Nadejda Vintonenko

Nadejda Vintonenko is a Senior Expert at Nanobiotix with a background in medical affairs and clinical development, particularly focused on Head & Neck cancers. Prior to their current role, Nadejda held positions in clinical operations, entrepreneurship, and as the CEO of the GORTEC - French Head & Neck Cancer Cooperative Group. Nadejda's experience also includes work as a Clinical Project Manager and Scientist in various research settings, exploring topics such as anti-VEGF therapy in malignant gliomas and immunotherapy for glioblastoma. Nadejda holds a PhD in Structural Biology and an Executive MBA.